BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yin R, Xu Y, Wang X, Yang L, Zhao D. Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment. Molecules 2022;27:3055. [PMID: 35630534 DOI: 10.3390/molecules27103055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Fittipaldi AS, Castrogiovanni D, Lufrano D, Saenz C, De Francesco PN, Lalonde T, Luyt LG, Cantel S, Fehrentz JA, Andreoli MF, Perello M. Ghrelin proteolysis increases in plasma of men, but not women, with obesity. Life Sci 2023;313:121305. [PMID: 36543283 DOI: 10.1016/j.lfs.2022.121305] [Reference Citation Analysis]
2 Andreadi A, Muscoli S, Tajmir R, Meloni M, Muscoli C, Ilari S, Mollace V, Della Morte D, Bellia A, Di Daniele N, Tesauro M, Lauro D. Recent Pharmacological Options in Type 2 Diabetes and Synergic Mechanism in Cardiovascular Disease. Int J Mol Sci 2023;24. [PMID: 36675160 DOI: 10.3390/ijms24021646] [Reference Citation Analysis]
3 Oura K, Morishita A, Tani J, Masaki T. Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma. J Hepatocell Carcinoma 2022;9:1279-98. [PMID: 36545268 DOI: 10.2147/JHC.S392051] [Reference Citation Analysis]
4 Antony P, Baby B, Aleissaee HM, Vijayan R. A Molecular Modeling Investigation of the Therapeutic Potential of Marine Compounds as DPP-4 Inhibitors. Mar Drugs 2022;20. [PMID: 36547924 DOI: 10.3390/md20120777] [Reference Citation Analysis]
5 Barchetta I, Cimini FA, Dule S, Cavallo MG. Dipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis. Biomedicines 2022;10:2306. [DOI: 10.3390/biomedicines10092306] [Reference Citation Analysis]
6 Pilszyk A, Niebrzydowska M, Pilszyk Z, Wierzchowska-Opoka M, Kimber-Trojnar Ż. Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus. Int J Mol Sci 2022;23:10101. [PMID: 36077491 DOI: 10.3390/ijms231710101] [Reference Citation Analysis]
7 Sun H, Qi X. The role of insulin and incretin-based drugs in biliary tract cancer: epidemiological and experimental evidence. Discov Onc 2022;13. [DOI: 10.1007/s12672-022-00536-8] [Reference Citation Analysis]
8 Hu X, Wang X, Xue X. Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases. Molecules 2022;27:4498. [DOI: 10.3390/molecules27144498] [Reference Citation Analysis]
9 Rogić S, Gagić Ž. 3D-QSAR-based pharmacophore determination and design of novel DPP-4 inhibitors. Scripta Medica 2022;53:271-279. [DOI: 10.5937/scriptamed53-40866] [Reference Citation Analysis]